Conventional management of type 2 diabetes has been based on drug therapy (oral antidiabetic agents and insulin injections) and behavioral (dietary restrictions and regular physical activity) interventions. Management of type 1 diabetes is based exclusively on multiple daily insulin injections.

For these patients, the disease is ever-present in day-to-day life requiring glycemic measurements, calculations of carbohydrate intake, and insulin injections. Reducing glucose self- monitoring and insulin injections would tremendously improve the quality of diabetics’ lives in particular for very young patients, adolescents, and elderly patients who have trouble with persistent self-control and vigilance demanding therapies.

The aim will be to

  • Reduce the daily controls and number of insulin injections, especially for T1DM patients.
  • Reduce of long-term side effects of current DM therapies and uncontrolled glucose levels